Valid for Submission
T48.6X5A is a billable code used to specify a medical diagnosis of adverse effect of antiasthmatics, initial encounter. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code T48.6X5A might also be used to specify conditions or terms like adverse reaction to antiasthmatic, adverse reaction to theobromine, aminophylline adverse reaction, bambuterol adverse reaction, bronchodilator preparations adverse reaction, choline theophyllinate adverse reaction, etc
The code T48.6X5A describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.
| ICD-10: | T48.6X5A |
| Short Description: | Adverse effect of antiasthmatics, initial encounter |
| Long Description: | Adverse effect of antiasthmatics, initial encounter |
Replaced Code
This code was replaced in the 2020 ICD-10 code set with the code(s) listed below. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2019. This code was replaced for the FY 2020 (October 1, 2019 - September 30, 2020).
- K59.03 - Drug induced constipation
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
- Unacceptable principal diagnosis - There are selected codes that describe a circumstance which influences an individual’s health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.
Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Adverse reaction to antiasthmatic
- Adverse reaction to theobromine
- Aminophylline adverse reaction
- Bambuterol adverse reaction
- Bronchodilator preparations adverse reaction
- Choline theophyllinate adverse reaction
- Cromoglycate and related antiallergenic adverse reaction
- Cromoglycate and related antiallergenic adverse reaction
- Fenoterol adverse reaction
- Flunisolide adverse reaction
- Inhaled isoprenaline adverse reaction
- Ipratropium adverse reaction
- Isoetharine hydrochloride adverse reaction
- Isoprenaline adverse reaction
- Nedocromil adverse reaction
- Oral isoprenaline adverse reaction
- Oxitropium adverse reaction
- Parenteral isoprenaline adverse reaction
- Phosphodiesterase inhibitor adverse reaction
- Pirbuterol adverse reaction
- Reproterol adverse reaction
- Rimiterol adverse reaction
- Salbutamol adverse reaction
- Salmeterol adverse reaction
- Sodium cromoglicate adverse reaction
- Terbutaline adverse reaction
- Theophylline adverse reaction
- Tulobuterol adverse reaction
- Xanthine adverse reaction
- Xanthine adverse reaction
- Xanthine adverse reaction
Convert T48.6X5A to ICD-9
- 995.29 - Adv eff med/biol NEC/NOS (Combination Flag)
- E945.7 - Adv eff antiasthmatics (Combination Flag)
Code Classification
Code History
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
(First year ICD-10-CM implemented into the HIPAA code set) - FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020